We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$62.7B
1-Year Est. Return
29.77%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+29.77%
3 Year Est. Return
+99.46%
5 Year Est. Return
+125.78%
10 Year Est. Return
–
AUM
$55.1B
AUM Growth
-$3.71B
(-6.3%)
Cap. Flow
-$2.01B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
15.88%
Holding
2,628
New
414
Increased
1,064
Reduced
775
Closed
261
Avg Time Held Equity + Options
4.8
quarters
Top 10 Avg Time Held Equity + Options
5.9
quarters
Top 20 Avg Time Held Equity + Options
3.8
quarters
Avg Time Held Equity only
4.9
quarters
Top 10 Avg Time Held Equity only
5.9
quarters
Top 20 Avg Time Held Equity only
4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$185M |
| 2 |
PepsiCo
PEP
|
+$176M |
| 3 |
TE Connectivity
TEL
|
+$166M |
| 4 |
Ford
F
|
+$131M |
| 5 |
3M
MMM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$352M |
| 3 |
Amazon
AMZN
|
+$296M |
| 4 |
NVIDIA
NVDA
|
+$237M |
| 5 |
Eaton
ETN
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Miscellaneous | 14.37% |
| 3 | Financials | 10.33% |
| 4 | Healthcare | 9.99% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2201
Alphatec Holdings
ATEC
$1.67B
| $206K | ﹤0.01% |
+18,971
| New | +$276K |
2026 Q1
0 quarters
|
|
2202
Metropolitan Bank Holding Corp
MCB
$1.07B
| $205K | ﹤0.01% |
+2,466
| New | +$212K |
2026 Q1
0 quarters
|
|
2203
AIRO Group Holdings
AIRO
$179M
| $203K | ﹤0.01% |
26,703
+10,722
| +67% | +$111K |
2025 Q3
2 quarters
|
|
2204
Omada Health Inc
OMDA
$1.12B
| $201K | ﹤0.01% |
+16,024
| New | +$221K |
2026 Q1
0 quarters
|
|
2205
CALL
Vertiv
VRT
$91.4B
| $200K | ﹤0.01% |
800
-4,100
| -84% | -$910K |
2025 Q1
4 quarters
|
|
|
2206
PUT
Vertiv
VRT
$91.4B
| $200K | ﹤0.01% |
800
-4,100
| -84% | -$910K |
2025 Q2
3 quarters
|
|
2207
CALL
Kohl's
KSS
$2.39B
| $194K | ﹤0.01% |
+15,000
| New | +$253K |
2026 Q1
0 quarters
|
|
|
2208
PUT
Kohl's
KSS
$2.39B
| $194K | ﹤0.01% |
+15,000
| New | +$253K |
2026 Q1
0 quarters
|
|
2209
Farmers National Banc Corp
FMNB
$889M
| $192K | ﹤0.01% |
14,583
-48,314
| -77% | -$634K |
2025 Q4
1 quarter
|
|
2210
Upstream Bio Inc
UPB
$194M
| $190K | ﹤0.01% |
+21,154
| New | +$381K |
2026 Q1
0 quarters
|
|
2211
Accelerant Holdings
ARX
$4.29B
| $189K | ﹤0.01% |
+14,144
| New | +$179K |
2026 Q1
0 quarters
|
|
2212
Optex Systems
OPXS
$69M
| $187K | ﹤0.01% |
+14,109
| New | +$195K |
2026 Q1
0 quarters
|
|
2213
Costamare
CMRE
$1.87B
| $183K | ﹤0.01% |
10,812
-1,035
| -9% | -$17.2K |
2025 Q4
1 quarter
|
|
2214
Cushman & Wakefield Ltd
CWK
$2.67B
| $182K | ﹤0.01% |
14,854
+4,822
| +48% | +$69.2K |
2025 Q4
1 quarter
|
|
2215
Freshworks
FRSH
$3.63B
| $180K | ﹤0.01% |
22,359
-227,056
| -91% | -$2.09M |
2023 Q4
9 quarters
|
|
2216
Absci
ABSI
$1.56B
| $179K | ﹤0.01% |
+59,761
| New | +$173K |
2026 Q1
0 quarters
|
|
2217
Radcom
RDCM
$171M
| $176K | ﹤0.01% |
+14,496
| New | +$173K |
2026 Q1
0 quarters
|
|
2218
Microvast
MVST
$213M
| $174K | ﹤0.01% |
116,138
+70,298
| +153% | +$169K |
2025 Q3
2 quarters
|
|
2219
CALL
Abercrombie & Fitch
ANF
$6.4B
| $174K | ﹤0.01% |
1,900
-1,100
| -37% | -$107K |
2025 Q4
1 quarter
|
|
|
2220
PUT
Abercrombie & Fitch
ANF
$6.4B
| $174K | ﹤0.01% |
1,900
-1,100
| -37% | -$107K |
2025 Q4
1 quarter
|
|
2221
Tredegar Corp
TG
$265M
| $173K | ﹤0.01% |
+21,733
| New | +$182K |
2026 Q1
0 quarters
|
|
2222
CALL
State Street Technology Select Sector SPDR ETF
XLK
$129B
| $173K | ﹤0.01% |
+1,300
| New | +$183K |
2026 Q1
0 quarters
|
|
|
2223
PUT
State Street Technology Select Sector SPDR ETF
XLK
$129B
| $173K | ﹤0.01% |
+1,300
| New | +$183K |
2026 Q1
0 quarters
|
|
2224
Lexicon Pharmaceuticals
LXRX
$716M
| $170K | ﹤0.01% |
+108,806
| New | +$158K |
2026 Q1
0 quarters
|
|
2225
Primis Financial Corp
FRST
$381M
| $169K | ﹤0.01% |
+12,757
| New | +$171K |
2026 Q1
0 quarters
|
|
Similar funds
NC
Man Group's Q1 2026 Portfolio in Review
As of Q1 2026, Man Group held 2,628 positions worth $55.1B, down 6.3% from $58.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Man Group withdrew a net $2.01B in Q1 2026, closing 261 positions and reducing 775 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Man Group opened a new position in AstraZeneca worth $122M.
- Man Group's largest Q1 2026 buy was AstraZeneca: 628,476 shares worth $122M.
- Man Group added most to HDFC Bank in Q1 2026, an estimated $185M increase.
- Man Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $352M.
- Man Group fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $418M.
- Man Group's ten largest holdings make up 16% of its $55.1B portfolio in Q1 2026.
- Man Group opened 414 new positions and closed 261 in Q1 2026.
- Man Group's portfolio value fell 6.3% quarter-over-quarter to $55.1B.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.